BOVACEPT Trademark

Trademark Overview

On Wednesday, February 17, 2021, a trademark application was filed for BOVACEPT with the United States Patent and Trademark Office. The USPTO has given the BOVACEPT trademark a serial number of 90532042. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by Covenant Animal Health Partners, LLC. The BOVACEPT trademark is filed in the Pharmaceutical Products category with the following description:

Synthetic analogue of prostaglandin in veterinary preparation
bovacept

General Information

Serial Number90532042
Word MarkBOVACEPT
Filing DateWednesday, February 17, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesSynthetic analogue of prostaglandin in veterinary preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCovenant Animal Health Partners, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66202
Party NameCovenant Animal Health Partners, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66202

Trademark Events

Event DateEvent Description
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 13, 2021ASSIGNED TO EXAMINER
Monday, September 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 20, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 14, 2022SOU EXTENSION 1 FILED
Tuesday, June 14, 2022SOU EXTENSION 1 GRANTED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 29, 2022SOU EXTENSION 2 FILED
Tuesday, November 29, 2022SOU EXTENSION 2 GRANTED
Thursday, December 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 9, 2023SOU EXTENSION 3 FILED
Friday, June 9, 2023SOU EXTENSION 3 GRANTED
Tuesday, June 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 12, 2023SOU EXTENSION 4 FILED
Tuesday, December 12, 2023SOU EXTENSION 4 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

bovacept preparation veterinary prostaglandin analogue synthetic